182 results on '"Narváez JA"'
Search Results
2. Renin-Angiotensin-Aldosterone System in Hyper- and Hypothyroid Rats During Sodium Depletion
- Author
-
Narváez Ja, Eugenio Jiménez, Mercedes Montiel, and M. Morell
- Subjects
Male ,endocrine system ,medicine.medical_specialty ,endocrine system diseases ,Sodium ,chemistry.chemical_element ,Hyperthyroidism ,Plasma renin activity ,Renin-Angiotensin System ,Hypothyroidism ,Internal medicine ,Renin–angiotensin system ,medicine ,Animals ,Euthyroid ,SODIUM DEPLETION ,Urinary sodium ,Chemistry ,Thyroid ,Rats, Inbred Strains ,General Medicine ,Diet, Sodium-Restricted ,Rats ,Endocrinology ,medicine.anatomical_structure ,Potassium ,Normal sodium ,Hyponatremia - Abstract
A study was made of the responses of the renin-angiotensin-aldosterone system (RAAS) produced in hyper- and hypothyroid rats maintained in a state of sodium depletion, as part of a wider study to effect a comparison with results previously obtained for the same parameters in rats maintained on a normal sodium diet and during experimental alterations of thyroid function. In hyperthyroid rats maintained on sodium deficient and normal sodium diet, and in euthyroid animals on a sodium deficient regimen, elevations of both plasma renin concentration (PRC) and serum aldosterone concentration (AC) were observed, while the plasma renin substrate (PRS) was decreased. In hypothyroid rats with normal sodium intake, PRC and AC were observed to be decreased relative to similar sodium-deficient animals. Relationships were observed between PRC and AC, and between AC and urinary sodium excretion. These results suggest that: i) Sodium depletion is a more effective stimulus than the thyroid hormones on the RAAS. ii) Aldosterone changes in sodium depletion are mediated by the RAS. iii) Sodium depletion appeared to induce a decrease in the hepatic synthesis of angiotensinogen.
- Published
- 1982
3. The Influence of Plasma Renin Substrate on the Relationship between Plasma Renin Activity and Plasma Renin Concentration
- Author
-
Luis Parras, Eugenio Jiménez, Narváez Ja, M T Miranda, M Morell, and Montiel M
- Subjects
medicine.medical_specialty ,animal structures ,Chemistry ,Endocrinology, Diabetes and Metabolism ,Biochemistry (medical) ,Clinical Biochemistry ,Endogeny ,General Medicine ,Biochemistry ,Plasma renin activity ,Endocrinology ,Plasma renin substrate ,Internal medicine ,Thyroid hormones ,medicine ,Propylthiouracil ,Thyroid function ,hormones, hormone substitutes, and hormone antagonists ,medicine.drug - Abstract
The effects of endogenous Plasma Renin Substrate (PRS) on the relationship between Plasma Renin Activity (PRA) and the Plasma Renin Concentration (PRC) have been studied in hyperthyroid rats, by I-triiodothyronine (T3) administration and in hypothyroid rats, by propylthiouracil (PTU) treatment, to clarify if PRA changes are an adequate index for evaluating the renin-angiotensin changes during the alterations in the thyroid function. Although in experimental situations studied the induced variation on PRC explains a 62 per cent of the changes in PRA, finding a good lineal correlation between both parameters (r = 0.79, P less than 0.001). Not only does PRS play an important role on the kinetic of the enzymatic reaction but also explains jointly with PRC up to a 85 per cent of PRA alterations. PRS changes become more important during thyrotoxicosis where they limit in a higher degree the velocity of reaction due to inverse relationship between PRC and PRS (r = 0.74, P less than 0.001).
- Published
- 1984
4. Renin-angiotensin system in hypothyroid rats: effects of potassium iodide and triiodo-L-thyronine
- Author
-
Eugenio Jiménez, Montiel M, Narváez Ja, and M. Morell
- Subjects
Male ,medicine.medical_specialty ,animal structures ,Endocrinology, Diabetes and Metabolism ,chemistry.chemical_element ,Iodine ,Plasma renin activity ,Renin-Angiotensin System ,chemistry.chemical_compound ,Electrolytes ,Endocrinology ,Hypothyroidism ,Plasma renin substrate ,Internal medicine ,Renin–angiotensin system ,Renin ,medicine ,Animals ,Potassium Iodide ,Rats, Inbred Strains ,General Medicine ,Rats ,Thyroxine ,chemistry ,Propylthiouracil ,Thyronine ,Thyroidectomy ,Triiodothyronine ,Previously treated ,hormones, hormone substitutes, and hormone antagonists ,medicine.drug - Abstract
Kinetic studies of the renin-angiotensin system (RAS) were carried out by measuring plasma renin activity (PRA), plasma renin concentration (PRC) and plasma renin substrate (PRS). Changes in this system were studied during hypothyroidism, after administration of propylthiouracil (PTU), and in thyroidectomized rats. A significant decrease in PRA and PRC was observed in those animals previously treated with PTU. However, a significant increase in PRC, and a decrease in PRS, were found in T animals, but no changes in PRA were observed. In these animals, after daily administration of potassium iodide for I week (T+KI), no changes in RAS were observed in comparison with T rats. Nevertheless, administration of daily doses of triiodo-ithyronine (T+T3) induced a significant increase in PRA, leaving PRC unaltered. In this case the changes in PRA were related to the increase in PRS after T3 treatment. These results suggest that two different mechanisms were involved in renin release, one activated in T rats and the other in pharmacological hypothyroidism.
5. Effect of various components of the renin-angiotensin-aldosterone system on angiotensinogen production in a monolayer culture of adult rat hepatocytes
- Author
-
Eugenio Jiménez, Montiel M, M. Ruiz, M Morell, Narváez Ja, and A. M. Diego
- Subjects
Male ,medicine.medical_specialty ,Hydrocortisone ,Endocrinology, Diabetes and Metabolism ,Clinical Biochemistry ,Angiotensinogen ,Biology ,Biochemistry ,Renin-Angiotensin System ,chemistry.chemical_compound ,Endocrinology ,Internal medicine ,Renin–angiotensin system ,medicine ,Animals ,Ouabain ,Incubation ,Aldosterone ,Cells, Cultured ,urogenital system ,Angiotensin II ,Biochemistry (medical) ,Monolayer culture ,Rats, Inbred Strains ,General Medicine ,Rats ,medicine.anatomical_structure ,chemistry ,Liver ,Cell culture ,Hepatocyte ,hormones, hormone substitutes, and hormone antagonists ,circulatory and respiratory physiology ,medicine.drug - Abstract
A monolayer culture of adult rat hepatocytes was used to study the effect of various components of the renin-angiotensin-aldosterone system (angiotensin II, aldosterone and angiotensinogen), and intracellular sodium depletion (by ouabaine addition) on the angiotensinogen production rate. Normal hepatocytes synthesized linearly angiotensinogen for 6 h at a mean rate of 110 pg angiotensin I generated/mg intracellular protein each h. The addition of hydrocortisone (0.1 microM) to the culture medium significantly enhanced the angiotensinogen production after 2 h of incubation (P less than 0.05), being about 2-fold higher than normal control values at the 6th h of incubation. In contrast to this increase, the addition of angiotensin II (70 nM) to the medium produced a higher stimulatory effect on angiotensinogen synthesis, being the differences with the control significants after 1 h of incubation (P less than 0.01). At the 6th h of incubation, angiotensin II enhanced the angiotensinogen production over 2 fold in relation to the control group. No change in the angiotensinogen production rate was observed in monolayer culture of hepatocytes in the presence of aldosterone (1 microM), angiotensinogen (0.1 microM) or ouabaine (10 microM). These results provide further evidence that angiotensinogen synthesis is subject to a positive feed-back mechanism by angiotensin II, indicating that this mechanism takes place at physiological levels of plasma AII.
6. Exploring radiographic patterns of the cervical spine, including zygapophyseal joints, in axial spondyloarthritis.
- Author
-
Berbel-Arcobé L, Benavent D, Michelena X, Narváez JA, Nolla JM, and Juanola X
- Subjects
- Male, Humans, Adult, Middle Aged, Aged, Female, Reproducibility of Results, Cervical Vertebrae diagnostic imaging, Zygapophyseal Joint diagnostic imaging, Spondylitis, Ankylosing diagnostic imaging, Spondylitis, Ankylosing epidemiology, Spondylarthritis diagnostic imaging, Spondylarthritis epidemiology
- Abstract
Introduction: The assessment of the cervical spine (CS) in axial spondyloarthritis (axSpA) and its radiographic characteristics, including the zygapophyseal joints (ZJ), may be helpful for an accurate diagnosis, establishing a prognosis and enhancing treatment decisions., Objectives: To describe the prevalence and characteristics of CS involvement in patients with axSpA and perform a comparison between groups according to cervical radiographic damage., Methods: Patients who fulfilled the Assessment of SpondyloArthritis International Society classification criteria were included from January 2011 to January 2021. Sociodemographic, clinical, radiographic and treatment variables were gathered. Patients were categorised into 'CS group' (Bath Ankylosing Spondylitis Radiology Index ≥2 or De Vlam score ≥3 for ZJ) and 'no CS group' as controls. ZJ fusion and interobserver reliability in ZJ scoring were analysed., Results: A total of 340 patients were included, 244 (71.7%) men, with mean age 57±15 years. CS involvement was observed in 181 (53.2%) patients. Patients in the CS group, as compared with no CS group, were predominantly men, older, had a higher body mass index, higher prevalence of smoking, showed higher disease activity, worse functionality and mobility, as well as more structural damage. Sixty-nine patients with CS involvement had ZJ fusion at some level. These patients showed worse mobility and more radiographic damage. Overall, ZJ involvement was observed in 99 patients (29.1%), 20 of whom did not present with vertebral body involvement., Conclusion: Radiographic evaluation of CS is relevant in patients with axSpA and should be assessed routinely. Evaluation of the ZJ is particularly significant, as it is related to higher disease activity and worse function., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF
7. The role of 2-[ 18 F]FDG PET/CT in Erdheim-Chester disease.
- Author
-
Pudis M, Palomar-Muñoz A, Solanich-Moreno X, Robles-Barba JJ, Rocamora-Blanch G, Rodríguez-Bel L, Narváez JA, and Cortés-Romera M
- Subjects
- Male, Humans, Middle Aged, Fluorodeoxyglucose F18, Positron-Emission Tomography, Mutation, Positron Emission Tomography Computed Tomography methods, Erdheim-Chester Disease diagnostic imaging, Erdheim-Chester Disease genetics, Erdheim-Chester Disease complications
- Abstract
Objective: To analyze the body distribution of Erdheim-Chester disease (ECD) and determine the utility of 2-[18 F]FDG PET/CT compared to other imaging techniques. Additionally, to assess the aggressiveness and extent of the disease based on the presence/absence of the BRAFV600E mutation., Materials and Methods: The 2-[
18 F]FDG-PET/CT scans of all patients diagnosed with ECD between 2008 and 2021 were reviewed, including 19 patients. The affected territories were classified as detectable by PET/CT or detectable only by other imaging techniques (bone scintigraphy, contrast-enhanced CT, or MRI). Descriptive analysis and correlation of the BRAF mutation with the affected organs and maximum SUV were performed using the Student's t-test., Results: Out of the 19 patients (14 males; mean age 60.3 years), 11 had the BRAFV600E mutation. A total of 127 territories (64 organ-systems) affected were identified using different imaging modalities, of which 112 were detected by PET/CT, and an additional 15 territories were solely identified by cerebral and cardiac MRI. The presence of BRAFV600E mutation was associated with greater organ involvement (p < 0.05) without differences in SUVmax (p > 0.05)., Conclusion: 2-[18 F]FDG PET/CT is a highly effective diagnostic tool in patients with ECD, detecting the majority of affected territories. MRI was the only imaging modality with additional findings in territories showing high physiological uptake of 2-[18 F]FDG (cerebral and cardiac). The presence of the BRAFV600E mutation correlated with a higher extent of the disease., (Copyright © 2023 Sociedad Española de Medicina Nuclear e Imagen Molecular. Published by Elsevier España, S.L.U. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
8. Current State and Proposal of Best Practices of Standardized Patients for Spanish-Language Objective Structured Clinical Encounters in US Medical Schools.
- Author
-
Iñiguez RX, Figueroa Narváez JA, Diamond LC, Gregorich SE, Karliner L, González J, Pérez-Cordón C, Shin TM, Izquierdo K, and Ortega P
- Abstract
Introduction: Medical Spanish programs commonly engage Spanish-speaking standardized patients (SPs) for communication skills assessment, yet no studies address SP recruitment, selection, or training., Methods: We sent questionnaires to medical Spanish faculty at 20 US medical schools to gauge their practices in recruiting and selecting Spanish-language SPs. We invited faculty to distribute a separate questionnaire to Spanish-language SPs to gather SP language abilities, training, and experience. We analyzed data using descriptive statistics and qualitative content analysis. When available, we reviewed SP video encounters to formally assess participating SPs' linguistic performance using the SP Oral Language Observation Matrix, a rating tool adapted from the Physician Oral Language Observation Matrix to assess oral medical Spanish proficiency., Results: Eighty percent of faculty (16/20) responded. Standardized patient recruitment sources included institutional English-language SPs, Hispanic student groups and professional organizations, communities, and language professionals. Faculty-reported strategies to determine language readiness included interviewing SP candidates in Spanish and asking them to self-rate language skills using a validated scale. Fifteen SPs (54%, 15/28) from 5 schools responded to the SP questionnaire, and one third (5/15) reported that their Spanish was not assessed before being selected as an SP. In addition, one third (5/15) did not receive any initial training before performing a medical Spanish case. Raters assessed 11 different SPs using the SP Oral Language Observation Matrix, and 6 were rated as linguistically "ready" for the SP role., Conclusions: Current approaches to recruitment, training, and language assessment of SPs vary. We propose strategies to ensure that medical Spanish encounters authentically reflect Spanish-speaking patients., Competing Interests: P.O., L.C.D., S.E.G., L.K., C.P.-C., and J.G. were supported by a grant from the National Board of Medical Examiners Stemmler Fund. L.C.D. was also supported by Memorial Sloan Kettering Cancer Center Support Grant/Core Grant (P30 CA008748). P.O. receives author royalties from Elsevier. L.C.D. receives author royalties from Multilingual Matters. The authors have no other conflicts of interest to report., (Copyright © 2023 Society for Simulation in Healthcare.)
- Published
- 2023
- Full Text
- View/download PDF
9. A Thermographic Disease Activity Index for remote assessment of rheumatoid arthritis.
- Author
-
Morales-Ivorra I, Narváez J, Gómez-Vaquero C, Moragues C, Nolla JM, Narváez JA, and Marín-López MA
- Subjects
- Humans, C-Reactive Protein, Inflammation, Thermography, Arthritis, Rheumatoid diagnosis, Synovitis
- Abstract
Objectives: Remote assessment of patients with rheumatoid arthritis (RA) has increased during recent years. However, telematic consultations preclude the possibility of carrying out a physical examination and obtaining objective inflammation. In this study, we developed and validated two novel composite disease activity indexes (Thermographic Disease Activity Index (ThermoDAI) and ThermoDAI-CRP) based on thermography of hands and machine learning, in order to assess disease activity easily, rapidly and without formal joint counts., Methods: ThermoDAI was developed as the sum of Thermographic Joint Inflammation Score (ThermoJIS), a novel joint inflammation score based on the analysis of thermal images of the hands by machine learning, the Patient Global Assessment (PGA) and, for ThermoDAI-CRP, the C reactive protein (CRP). Construct validity was tested in 146 patients with RA by using Spearman's correlation with ultrasound-determined grey-scale synovial hypertrophy (GS) and power Doppler (PD) scores, CDAI, SDAI and DAS28-CRP., Results: Correlations of ultrasound scores with ThermoDAI (GS=0.52; PD=0.56) and ThermoDAI-CRP (GS=0.58; PD=0.61) were moderate to strong, while the correlations of ultrasound scores with PGA (GS=0.35; PD=0.39) and PGA+CRP (GS=0.44; PD=0.46) were weak to moderate. ThermoDAI and ThermoDAI-CRP also showed strong correlations with Clinical Disease Activity Index (ρ>0.83), Simplified Disease Activity Index (ρ>0.85) and Disease Activity Score with 28-Joint Counts-CRP (ρ>0.81) and high sensitivity for detecting active synovitis using remission criteria., Conclusions: ThermoDAI and ThermoDAI-CRP showed stronger correlations with ultrasound-determined synovitis than PGA and PGA + CRP, thus presenting an opportunity to improve remote consultations with patients with RA., Competing Interests: Competing interests: IM-I and MAM-L are cofounders and shareholders of Singularity Biomed., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
10. Assessment of inflammation in patients with rheumatoid arthritis using thermography and machine learning: a fast and automated technique.
- Author
-
Morales-Ivorra I, Narváez J, Gómez-Vaquero C, Moragues C, Nolla JM, Narváez JA, and Marín-López MA
- Subjects
- Humans, Inflammation diagnosis, Machine Learning, Thermography, Arthritis, Rheumatoid complications, Arthritis, Rheumatoid diagnosis, Osteoarthritis, Synovitis diagnostic imaging, Synovitis etiology
- Abstract
Objectives: Sensitive detection of joint inflammation in rheumatoid arthritis (RA) is crucial to the success of the treat-to-target strategy. In this study, we characterise a novel machine learning-based computational method to automatically assess joint inflammation in RA using thermography of the hands, a fast and non-invasive imaging technique., Methods: We recruited 595 patients with arthritis and osteoarthritis, as well as healthy subjects at two hospitals over 4 years. Machine learning was used to assess joint inflammation from the thermal images of the hands using ultrasound as the reference standard, obtaining a Thermographic Joint Inflammation Score (ThermoJIS). The machine learning model was trained and tuned using data from 449 participants with different types of arthritis, osteoarthritis or without rheumatic disease (development set). The performance of the method was evaluated based on 146 patients with RA (validation set) using Spearman's rank correlation coefficient, area under the receiver-operating curve (AUROC), average precision, sensitivity, specificity, positive and negative predictive value and F1-score., Results: ThermoJIS correlated moderately with ultrasound scores (grey-scale synovial hypertrophy=0.49, p<0.001; and power Doppler=0.51, p<0.001). The AUROC for ThermoJIS for detecting active synovitis was 0.78 (95% CI, 0.71 to 0.86; p<0.001). In patients with RA in clinical remission, ThermoJIS values were significantly higher when active synovitis was detected by ultrasound., Conclusions: ThermoJIS was able to detect joint inflammation in patients with RA, even in those in clinical remission. These results open an opportunity to develop new tools for routine detection of joint inflammation., Competing Interests: Competing interests: IM-I and MAM-L are cofounders and shareholders of Singularity Biomed. Singularity Biomed has filed a patent application for the computational method., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
11. Proliferative synovitis, an ultrasound pattern associated with ACPA-positive patients and erosive disease in rheumatoid arthritis.
- Author
-
Ramírez J, Azuaga-Piñango AB, Frade-Sosa B, Gumucio-Sanguino R, Cajiao-Sánchez K, Cuervo AM, Celis R, Narváez JA, Ruiz-Esquide V, Castellanos-Moreira R, Ponce A, Gómez-Puerta JA, Pablos JL, Sanmartí R, and Cañete JD
- Subjects
- Autoantibodies, Humans, Ultrasonography methods, Ultrasonography, Doppler, Antirheumatic Agents therapeutic use, Arthritis, Rheumatoid complications, Arthritis, Rheumatoid diagnostic imaging, Arthritis, Rheumatoid drug therapy, Synovitis diagnostic imaging, Synovitis drug therapy
- Abstract
Objectives: To analyse ultrasound (US) differences between rheumatoid arthritis (RA) patients according to autoantibody status and characterise the clinical and radiological features associated with the US pattern of seropositive patients., Methods: We collected demographic and clinical data and bilateral hand US images of RA patients. We defined an extreme proliferative US pattern, encompassing synovial hypertrophy grade II-III with Power Doppler signal, which we called US proliferative synovitis (US PS). To better characterise US PS, MRI of the dominant hand and immunostaining of synovial biopsies were made in subgroups of 42 and 23 patients, respectively., Results: We included 205 RA patients (84.8% seropositive). No significant differences in disease activity were found according to autoantibody status. US PS was found in 55.5% of seropositive and 16.1% of seronegative patients (p=0.0001). In the multivariate analysis, erosions [OR 4.90 95% CI (2.17-11.07), p=0.0001] and ACPA [OR 3.5 95% CI (1.39-10.7), p=0.009] but not RF status [OR 0.74 95% CI (0.31-1.71), p=0.483] were independently associated with US PS. After a mean follow-up of 46 months, US PS was independently associated with changes in therapy (OR 2.63, 95% CI 1.20-5.77, p=0.016). Ninety-four per cent of joints with US PS had RAMRIS synovitis sub-index grade 2-3. US PS was significantly associated with higher synovial vessel density (p=0.042)., Conclusions: In RA patients, US PS was associated with ACPA status, erosive disease and an enhanced need to change disease-modifying anti-rheumatic drug therapy in the long-term. At synovial level, this US pattern was characterised by higher vessel density.
- Published
- 2022
- Full Text
- View/download PDF
12. Galanin (1-15) Enhances the Behavioral Effects of Fluoxetine in the Olfactory Bulbectomy Rat, Suggesting a New Augmentation Strategy in Depression.
- Author
-
Flores-Burgess A, Millón C, Gago B, García-Durán L, Cantero-García N, Puigcerver A, Narváez JA, Fuxe K, Santín L, and Díaz-Cabiale Z
- Subjects
- Animals, Antidepressive Agents pharmacology, Corticosterone, Galanin pharmacology, Humans, Peptide Fragments, RNA, Messenger, Rats, Rats, Sprague-Dawley, Sucrose, Depression drug therapy, Depression metabolism, Fluoxetine pharmacology
- Abstract
Background: Selective serotonergic reuptake inhibitors, including fluoxetine (FLX), are the most commonly used for the treatment of major depression. However, they are effective for remission in only 30% of patients. Recently, we observed that Galanin (1-15) [GAL(1-15)] enhanced the antidepressant effects of FLX in naïve animals, suggesting a new augmentation strategy in depression., Methods: We have analyzed in an animal model of depression, the olfactory bulbectomy (OBX) rats, the effect of GAL(1-15) on FLX-mediated responses in the forced swimming test and the sucrose preference test and the involvement of GAL receptor 2 with its antagonist, M871. We have also studied the corticosterone levels in OBX after the coadministration of GAL(1-15) with FLX. Moreover, we studied whether the effects of GAL(1-15) on FLX actions were mediated via auto- and heteroreceptor 5-HT1A (5-HT1AR), analyzing the binding characteristics, mRNA levels, and functionality of 5-HT1AR in the dorsal hippocampus., Results: GAL(1-15) enhances the antidepressant-like effects induced by FLX in OBX animals in the forced swimming test and the sucrose preference test. The involvement of the GALR2 was demonstrated with M871. Importantly, the mechanism underlying the GAL(1-15)/FLX interactions in the OBX animals involves the 5-HT1AR in the hippocampus at the plasma membrane (increase of affinity and density of 5HT1AR in the DG) and transcriptional (increase of 5HT1AR mRNA levels in DG and CA1) levels. Besides, the coadministration of GAL(1-15) and FLX also reduced OBX-increased corticosterone levels., Conclusions: The results open the possibility to use GAL(1-15) in combination with FLX as a novel strategy for the treatment of depression., (© The Author(s) 2021. Published by Oxford University Press on behalf of CINP.)
- Published
- 2022
- Full Text
- View/download PDF
13. Non-invasive vagus nerve stimulation for rheumatoid arthritis: a proof-of-concept study.
- Author
-
Marsal S, Corominas H, de Agustín JJ, Pérez-García C, López-Lasanta M, Borrell H, Reina D, Sanmartí R, Narváez J, Franco-Jarava C, Peterfy C, Narváez JA, Sharma V, Alataris K, Genovese MC, and Baker MC
- Abstract
Background: Vagus nerve stimulation delivered with an implanted device has been shown to improve rheumatoid arthritis severity. We aimed to investigate the safety and efficacy of non-invasive stimulation of the auricular branch of the vagus nerve for the treatment of patients with moderately to severely active rheumatoid arthritis., Methods: This prospective, multicentre, open-label, single-arm proof-of-concept study enrolled patients aged 18-80 years with active rheumatoid arthritis who had an inadequate response to conventional synthetic disease-modifying antirheumatic drugs (DMARDs) and up to one biological DMARD. Biological DMARDs were stopped at least 4 weeks before enrolment and concomitant use was not allowed during the study. All eligible participants were assigned to use a non-invasive, wearable vagus nerve stimulation device for up to 30 min per day, which delivered pulses of 20 kHz. Follow-up visits occurred at week 1, week 2, week 4, week 8, and week 12 after the baseline visit. The primary endpoint was the mean change in Disease Activity Score of 28 joints with C-reactive protein (DAS28-CRP) at week 12 compared with baseline. Secondary endpoints included the mean change in the Health Assessment Questionnaire-Disability Index (HAQ-DI), the proportion of patients with a minimal clinically important difference of 0·22 on HAQ-DI, the proportion achieving American College of Rheumatology (ACR) 20, ACR50, and ACR70 response, and safety analysis. This study is registered with ClinicalTrials.gov (NCT04116866)., Findings: Of 35 patients screened for eligibility, 30 (86%) were enrolled at six centres in Spain between Dec 27, 2018, and Oct 24, 2019, of whom 27 (90%) completed the week 12 visit. The mean change in DAS28-CRP at 12 weeks was -1·4 (95%CI -1·9 to -0·9; p<0·0001) from a mean baseline of 5·3 (SD 1·0). 11 (37%) of 30 patients reached DAS28-CRP of 3·2 or less, and seven (23%) patients reached DAS28-CRP of less than 2·6 at week 12. The mean HAQ-DI change was -0·5 (95%CI -0·7 to -0·2; p<0·0001) from a mean baseline of 1·6 (SD 0·7), and 17 (57%) patients reached a minimal clinically important difference of 0·22 or more. ACR20 responses were reached by 16 (53%) patients, ACR50 responses by 10 (33%) patients, and ACR70 by five (17%) patients. Four adverse events were reported, none of which were serious and all of which resolved without intervention., Interpretation: Use of the device was well tolerated, and patients had clinically meaningful reductions in DAS28-CRP. This was an uncontrolled, open-label study, and the results must be interpreted in this context. Further evaluation in larger, controlled studies is needed to confirm whether this non-invasive approach might offer an alternative treatment for rheumatoid arthritis., Funding: Nēsos., (Copyright © 2021 Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
14. Biomarkers for treatment change and radiographic progression in patients with rheumatoid arthritis in remission: a 5 year follow-up study.
- Author
-
Ramírez J, Cuervo A, Celis R, Ruiz-Esquide V, Castellanos-Moreira R, Narváez JA, Gómez-Puerta JA, Pablos JL, Sanmartí R, and Cañete JD
- Subjects
- Arthritis, Rheumatoid diagnosis, Arthritis, Rheumatoid drug therapy, Biomarkers metabolism, Biopsy, Blood Sedimentation, Disease Progression, Follow-Up Studies, Prospective Studies, Remission Induction, Severity of Illness Index, Time Factors, Antirheumatic Agents therapeutic use, Arthritis, Rheumatoid metabolism, Radiography methods
- Abstract
Objective: To identify biomarkers of treatment change and radiographic progression in patients with RA under remission., Patients and Methods: RA patients in remission (DAS28-ESR <2.6) were selected and followed up for 5 years. An MRI of the dominant hand and an US assessment of knees/hands and serum levels of inflammation/angiogenesis biomarkers were performed at baseline and at 12th month. Synovial biopsies were obtained in patients with Power Doppler signal. Conventional radiographies of hands/feet were taken at baseline and after 5 years. Radiographic progression was defined as the change in the modified Sharp van der Heijde Score at 5 years >10.47 (small detectable change)., Results: Sixty patients were included, 81.6% were ACPA+ and 45% were taking biological DMARDs. At baseline, 66.6% had Power Doppler signal. After 5 years, 73.3% of patients remained in remission. Change of therapy was performed in 20 patients (33.3%) and was associated with BMI [odds ratio (OR) 1.3, 95% CI: 1, 1.7], lack of biological DMARD therapy (OR 24.7, 95% CI: 2.3, 257.2), first-year progression of MRI erosions (OR 1.2, 95% CI: 1, 1.3) and calprotectin serum levels (OR 2.8, 95% CI: 1, 8.2). Radiographic progression occurred in six (10%) patients. These patients had higher first-year progression of MRI erosions (P = 0.03) and bone oedema (P = 0.04). Among 23 patients undergoing synovial biopsy, mast cell density was independently associated with clinical flares., Conclusions: One-third of RA patients lost clinical remission and changed therapy throughout the 5 years of follow-up, which was independently associated with BMI, lack of biological DMARDs therapy and first-year progression of MRI erosion score and calprotectin serum levels. Significant radiographic progression was uncommon., (© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2021
- Full Text
- View/download PDF
15. Influence of Preoperative Muscle Mass Assessed by Computed Tomography on Prognosis After Liver Transplantation.
- Author
-
Cabo SN, León Díaz FJ, Segura JS, Muñoz DC, Pérez BS, Montiel Casado MC, Pérez Daga JA, Narváez JA, Fernández Aguilar JL, Suárez Muñoz MA, and Santoyo JS
- Subjects
- Adult, Aged, Female, Humans, Incidence, Male, Middle Aged, Postoperative Complications etiology, Preoperative Period, Prognosis, Psoas Muscles diagnostic imaging, Psoas Muscles pathology, Retrospective Studies, Risk Factors, Sarcopenia complications, Sarcopenia mortality, Survival Rate, Liver Transplantation adverse effects, Postoperative Complications mortality, Sarcopenia diagnostic imaging, Tomography, X-Ray Computed
- Abstract
Background: Sarcopenia (SP) and preoperative muscle mass are independent predictive factors for short- and long-term outcome of liver transplantation., Objective: To assess the influence of muscle mass index (MMI) and preoperative SP on the prognosis of patients who underwent liver transplantation in our hospital., Methods: Ninety-seven patients who underwent liver transplantation in the Regional University Hospital of Málaga from September 2013 to March 2016 were analyzed. SP was determined based on the MMI, as assessed by psoas muscle area at the L4 level measured by computed tomography (CT), with adjustment for patient sex. Two cohorts were differentiated: 54 patients without SP and 42 patients with SP. Postoperative complications, graft survival, and patient survival were assessed. A 3-year follow-up was carried out., Results: Recipient characteristics were similar in both cohorts, except for MMI ± SD (group without SP: 94.03 ± 15.43 cm2/m2 vs group with SP: 56.99 ± 13.59 cm2/m2; P = .001). The incidence of postoperative complications (Clavien ≥ 3) in patients with and without SP was 39.5% and 24.1%, respectively (P = .08). SP was not associated with poorer long-term graft or patient survival., Conclusions: SP, determined by preoperative measurement of MMI, was identified as a predictive factor associated with a higher incidence of postoperative complications. Since MMI can be easily determined by CT, it should be assessed in all candidates for liver transplantation., (Published by Elsevier Inc.)
- Published
- 2020
- Full Text
- View/download PDF
16. Imaging of skull vault tumors in adults.
- Author
-
Pons Escoda A, Naval Baudin P, Mora P, Cos M, Hernandez Gañan J, Narváez JA, Aguilera C, and Majós C
- Abstract
The skull vault, formed by the flat bones of the skull, has a limited spectrum of disease that lies between the fields of neuro- and musculoskeletal radiology. Its unique abnormalities, as well as other ubiquitous ones, present particular features in this location. Moreover, some benign entities in this region may mimic malignancy if analyzed using classical bone-tumor criteria, and proper patient management requires being familiar with these presentations. This article is structured as a practical review offering a systematic diagnostic approach to focal calvarial lesions, broadly organized into four categories: (1) pseudolesions: arachnoid granulations, meningo-/encephaloceles, vascular canals, frontal hyperostosis, parietal thinning, parietal foramina, and sinus pericrani; (2) lytic: fibrous dysplasia, epidermal inclusion and dermoid cysts, eosinophilic granuloma, hemangioma, aneurysmal bone cyst, giant cell tumor, metastasis, and myeloma; (3) sclerotic: osteomas, osteosarcoma, and metastasis; (4) transdiploic: meningioma, hemangiopericytoma, lymphoma, and metastasis, along with other less common entities. Tips on the potential usefulness of functional imaging techniques such as MR dynamic susceptibility (T2*) perfusion, MR spectroscopy, diffusion-weighted imaging, and PET imaging are provided.
- Published
- 2020
- Full Text
- View/download PDF
17. Galanin (1-15)-fluoxetine interaction in the novel object recognition test. Involvement of 5-HT1A receptors in the prefrontal cortex of the rats.
- Author
-
Flores-Burgess A, Millón C, Gago B, García-Durán L, Cantero-García N, Coveñas R, Narváez JA, Fuxe K, Santín L, and Díaz-Cabiale Z
- Subjects
- Animals, Drug Interactions physiology, Fluoxetine toxicity, Galanin pharmacology, Galanin therapeutic use, Male, Memory Disorders chemically induced, Memory Disorders drug therapy, Memory Disorders metabolism, Neuropeptides metabolism, Neuropeptides pharmacology, Neuropeptides therapeutic use, Peptide Fragments pharmacology, Peptide Fragments therapeutic use, Prefrontal Cortex drug effects, Rats, Rats, Sprague-Dawley, Recognition, Psychology physiology, Selective Serotonin Reuptake Inhibitors toxicity, Fluoxetine metabolism, Galanin metabolism, Peptide Fragments metabolism, Prefrontal Cortex metabolism, Receptor, Serotonin, 5-HT1A metabolism, Recognition, Psychology drug effects, Selective Serotonin Reuptake Inhibitors metabolism
- Abstract
Galanin (1-15) [GAL(1-15)] participates in mood regulation and depression. GAL(1-15) is also able to enhance the antidepressant effects induced by Fluoxetine (FLX) in the forced swimming test through interaction between GALR1-GALR2 and 5-HT1A receptors that induced changes in the binding characteristics and mRNA of the 5-HT1AR in the hippocampus. Since the medial prefrontal cortex (mPFC) is a core region for the interaction between emotional processing and cognition with a high density of 5-HT1AR and GALR1 and GALR2, we have analyzed the binding characteristics and mRNA levels of 5-HT1AR in the mPFC after GAL(1-15)-FLX administration in the rats. GAL(1-15) increased the Kd and the Bmax of the 5HT1AR agonist binding in the mPFC as well as the mRNA levels of 5-HT1AR in mPFC. Moreover, GAL(1-15) reversed the effects of memory impairment induced by FLX(10 mg/kg) in the Novel Object Recognition task. GALR2 was involved in these effects, since the specific GALR2 antagonist M871 blocked GAL(1-15) mediated actions at behavioral level. On the contrary GAL(1-15) did not reverse the effect of FLX in the Object Location Memory task. In conclusion, our results describe an interactions between GAL(1-15) and FLX in the mPFC involving interactions at the 5-HT1AR receptor level in the plasma membrane with changes at the transcriptional level with implications also at functional level. The GALR1-GALR2-5-HT1A heteroreceptor could be postulated to be used to reverse some of the adverse effects of FLX on memory processes., (Copyright © 2019 Elsevier Ltd. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
18. Update on Whole-body MRI in Musculoskeletal Applications.
- Author
-
Vilanova JC, García-Figueiras R, Luna A, Baleato-González S, Tomás X, and Narváez JA
- Subjects
- Humans, Musculoskeletal System diagnostic imaging, Magnetic Resonance Imaging methods, Musculoskeletal Diseases diagnostic imaging, Whole Body Imaging methods
- Abstract
Whole-body magnetic resonance imaging (WB-MRI) is a powerful tool increasingly used to assess oncologic and nononcologic diseases. WB-MRI provides information about diffuse multifocal pathologies with excellent anatomical definition through high soft tissue contrast and spatial resolution as well as valuable functional information from diffusion-weighted images. In addition to its roles in establishing the diagnosis and assessing the extent and severity of disease, WB-MRI is also useful for monitoring the response to treatment for malignant and benign systemic diseases affecting the musculoskeletal system. This article reviews and updates the applications of WB-MRI in current practice, discussing the role of this helpful tool in various conditions involving the musculoskeletal system including bone metastases, hematologic cancers, inflammatory processes, infections, and multisystemic-multifocal bone, nerve, vascular, and muscle/soft tissue disorders, as well as other idiopathic conditions., Competing Interests: None declared., (Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.)
- Published
- 2019
- Full Text
- View/download PDF
19. Role of the galanin N-terminal fragment (1-15) in anhedonia: Involvement of the dopaminergic mesolimbic system.
- Author
-
Millón C, Flores-Burgess A, Gago B, Alén F, Orio L, García-Durán L, Narváez JA, Fuxe K, Santín L, and Díaz-Cabiale Z
- Subjects
- Animals, Behavior, Animal physiology, Depression metabolism, Dopamine Plasma Membrane Transport Proteins metabolism, Female, Male, Nucleus Accumbens metabolism, Proto-Oncogene Proteins c-fos metabolism, Rats, Rats, Sprague-Dawley, Ventral Tegmental Area metabolism, Vesicular Monoamine Transport Proteins metabolism, Anhedonia physiology, Dopamine metabolism, Galanin metabolism, Receptors, Dopamine metabolism
- Abstract
Background: Anhedonia is a core feature of depressive disorders. The galanin N-terminal fragment (1-15) plays a role in mood regulation since it induces depression and anxiogenic-like effects in rats. In this study, we analysed galanin N-terminal fragment (1-15) actions in anhedonic-like behaviours in rats using operant and non-operant tests and the areas involved with these effects., Methods: Galanin N-terminal fragment (1-15) effects were analysed in saccharin self-administration, sucrose preference, novelty-suppressed feeding and female urine sniffing tests. The areas involved in galanin N-terminal fragment (1-15)-mediated effects were studied with positron emission tomography for in vivo imaging, and we analysed the ventral tegmental area and nucleus accumbens. Galanin N-terminal fragment (1-15) had effects on the mRNA expression of the dopamine transporters Dat and Vmat2; the C-Fos gene; the dopamine receptors D1, D2, D3, D5; and the galanin receptors 1 and 2., Results: Galanin N-terminal fragment (1-15) at a concentration of 3 nmol induced a strong anhedonia-like phenotype in all tests. The involvement of galanin receptor 2 was demonstrated with the galanin receptor 2 antagonist M871 (3 nmol). The 18F-fluorodeoxyglucose positron emission tomography images indicated the action of galanin N-terminal fragment (1-15) over several nuclei of the limbic system. Galanin N-terminal fragment (1-15)-mediated effects also involved changes in the expression of Dat, Vmat2, D3 and galanin receptors in the ventral tegmental area as well as the expression of C-Fos, D1, D2 and D3 and TH immunoreactivity in the nucleus accumbens., Conclusions: Our results indicated that galanin N-terminal fragment (1-15) exerts strong anhedonic-like effects and that this effect was accompanied by changes in the dopaminergic mesolimbic system. These results may provide a basis for the development of novel therapeutic strategies using galanin N-terminal fragment (1-15) analogues for the treatment of depression and reward-related diseases.
- Published
- 2019
- Full Text
- View/download PDF
20. Central administration of galanin N-terminal fragment 1-15 decreases the voluntary alcohol intake in rats.
- Author
-
Millón C, Flores-Burgess A, Castilla-Ortega E, Gago B, García-Fernandez M, Serrano A, Rodriguez de Fonseca F, Narváez JA, Fuxe K, Santín L, and Díaz-Cabiale Z
- Subjects
- Animals, Central Nervous System Depressants pharmacology, Ethanol pharmacology, Injections, Intraventricular, Locomotion drug effects, Neostriatum metabolism, Peptides pharmacology, Proto-Oncogene Proteins c-fos genetics, Proto-Oncogene Proteins c-fos metabolism, Rats, Receptor, Galanin, Type 1 drug effects, Receptor, Galanin, Type 1 genetics, Receptor, Galanin, Type 1 metabolism, Receptor, Galanin, Type 2 antagonists & inhibitors, Receptor, Galanin, Type 2 drug effects, Receptor, Galanin, Type 2 genetics, Receptor, Galanin, Type 2 metabolism, Self Administration, rab5 GTP-Binding Proteins genetics, rab5 GTP-Binding Proteins metabolism, Alcohol Drinking, Behavior, Animal drug effects, Central Nervous System Depressants administration & dosage, Ethanol administration & dosage, Galanin pharmacology, Peptide Fragments pharmacology
- Abstract
Alcohol consumption is considered a major risk factor for disease and mortality worldwide. In the absence of effective treatments in alcohol use disorders, it is important to find new biological targets that could modulate alcohol consumption. We tested the role of the N-terminal galanin fragment (1-15) [GAL(1-15)] in voluntary ethanol consumption in rats using the two-bottle choice paradigm as well as compare the effects of GAL(1-15) with the whole molecule of GAL. We describe for the first time that GAL(1-15), via central mechanisms, induces a strong reduction in preference and ethanol consumption in rats. These effects were significantly different than GAL. GAL receptor (GALR) 2 was involved in these effects, because the specific GALR2 antagonist M871 blocked GAL(1-15) mediated actions in preference and ethanol intake. Importantly, the mechanism of this action involves changes in GALR expression and also in immediate-early gene C-Fos and receptors-internalization-related gene Rab5 in the striatum. The relevance of the striatum as a target for GAL(1-15) was supported by the effect of GAL(1-15) on the locomotor activity of rats after ethanol administration. These results may give the basis for the development of novel therapeutics strategies using GAL(1-15) analogues for the treatment of alcohol use disorders in humans., (© 2017 Society for the Study of Addiction.)
- Published
- 2019
- Full Text
- View/download PDF
21. Rheumatic immune-related adverse events in patients on anti-PD-1 inhibitors: Fasciitis with myositis syndrome as a new complication of immunotherapy.
- Author
-
Narváez J, Juarez-López P, LLuch J, Narváez JA, Palmero R, García Del Muro X, Nolla JM, and Domingo-Domenech E
- Subjects
- Humans, Inflammation chemically induced, Neoplasms drug therapy, Prospective Studies, Rheumatic Diseases immunology, Antineoplastic Agents, Immunological adverse effects, Immunotherapy adverse effects, Programmed Cell Death 1 Receptor antagonists & inhibitors, Rheumatic Diseases chemically induced
- Abstract
Objective: To evaluate the prevalence and type of rheumatic immune-related adverse events (IRAEs) in patients receiving programmed cell death protein-1 (PD-1) inhibitors., Methods: This is a single-center prospective observational study, including all cancer patients receiving PD-1 inhibitors between January 2016 and January 2018., Results: During the period analyzed, we evaluated a total of 11 patients. No patient had pre-existing rheumatic or autoimmune disease. In this period, a total of 220 patients were treated with PD1 inhibitors in our center; therefore, the estimated minimum prevalence of rheumatic IRAEs related to these therapies in our population was 5%. The rheumatic IRAEs evaluated included 5 cases of oligo- or polyarthritis, 1 with a polymialgia rheumatica-type syndrome, 2 cases of immunotherapy-induced sicca syndrome, 2 patients who presented symptomatic inflammatory myositis with fasciitis in lower extremities, and 1 patient with a paraneoplastic acral vascular syndrome. The median time to IRAE after anti-PD1 exposure was 8 weeks (range: 2-24). In 5 patients, immunotherapy was discontinued (due to the adverse effect in three and cancer progression in two). In general terms the symptoms resolved completely with symptomatic treatment. Disease-modifying antirheumatic drugs were needed for 2 patients., Conclusion: Rheumatic IRAEs should be kept in mind during the follow-up and evaluation of patients treated with PD-1 inhibitors. The concomitant development of symptomatic inflammatory myositis with fasciitis in lower extremities appears to be a new adverse effect of anti-PD-1 immunotherapy. Additional studies are needed to determine how to adequately control and manage these complications., (Copyright © 2018 Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
22. Acute Calcific Tendinitis of the Longus Colli Muscle.
- Author
-
Narváez J, Morales-Ivorra I, Martínez-Yelamos S, and Narváez JA
- Subjects
- Acute Pain etiology, Anti-Inflammatory Agents therapeutic use, Blood Sedimentation, Braces, C-Reactive Protein analysis, Calcinosis therapy, Colchicine therapeutic use, Deglutition Disorders etiology, Female, Fever etiology, Gout Suppressants therapeutic use, Humans, Leukocytosis etiology, Magnetic Resonance Imaging, Middle Aged, Neck Pain etiology, Prednisone therapeutic use, Tendinopathy therapy, Tomography, X-Ray Computed, Calcinosis diagnostic imaging, Neck Muscles diagnostic imaging, Tendinopathy diagnosis
- Published
- 2018
- Full Text
- View/download PDF
23. Recommendations for the Use of Ultrasound and Magnetic Resonance in Patients With Spondyloarthritis, Including Psoriatic Arthritis, and Patients With Juvenile Idiopathic Arthritis.
- Author
-
Uson J, Loza E, Möller I, Acebes C, Andreu JL, Batlle E, Bueno Á, Collado P, Fernández-Gallardo JM, González C, Jiménez Palop M, Lisbona MP, Macarrón P, Maymó J, Narváez JA, Navarro-Compán V, Sanz J, Rosario MP, Vicente E, and Naredo E
- Subjects
- Humans, Ultrasonography, Arthritis, Juvenile diagnostic imaging, Arthritis, Psoriatic diagnostic imaging, Magnetic Resonance Imaging, Spondylarthritis diagnostic imaging
- Abstract
Objective: To develop evidence-based recommendations on the use of ultrasound (US) and magnetic resonance imaging in patients with spondyloarthritis, including psoriatic arthritis, and juvenile idiopathic arthritis., Methods: Recommendations were generated following a nominal group technique. A panel of experts (15 rheumatologists and 3 radiologists) was established in the first panel meeting to define the scope and purpose of the consensus document, as well as chapters, potential recommendations and systematic literature reviews (we used and updated those from previous EULAR documents). A first draft of recommendations and text was generated. Then, an electronic Delphi process (2 rounds) was carried out. Recommendations were voted from 1 (total disagreement) to 10 (total agreement). We defined agreement if at least 70% of participants voted≥7. The level of evidence and grade or recommendation was assessed using the Oxford Centre for Evidence Based Medicine levels of evidence. The full text was circulated and reviewed by the panel. The consensus was coordinated by an expert methodologist., Results: A total of 12 recommendations were proposed for each disease. They include, along with explanations of the validity of US and magnetic resonance imaging regarding inflammation and damage detection, diagnosis, prediction (structural damage progression, flare, treatment response, etc.), monitoring and the use of US guided injections/biopsies., Conclusions: These recommendations will help clinicians use US and magnetic resonance imaging in patients with spondyloarthritis and juvenile idiopathic arthritis., (Copyright © 2016 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
24. Recommendations for the use of ultrasound and magnetic resonance in patients with rheumatoid arthritis.
- Author
-
Möller I, Loza E, Uson J, Acebes C, Andreu JL, Batlle E, Bueno Á, Collado P, Fernández-Gallardo JM, González C, Jiménez Palop M, Lisbona MP, Macarrón P, Maymó J, Narváez JA, Navarro-Compán V, Sanz J, Rosario MP, Vicente E, and Naredo E
- Subjects
- Antirheumatic Agents therapeutic use, Arthritis, Rheumatoid drug therapy, Delphi Technique, Drug Monitoring, Evidence-Based Medicine, Humans, Ultrasonography, Arthritis, Rheumatoid diagnostic imaging, Magnetic Resonance Imaging
- Abstract
Objective: To develop evidence-based recommendations on the use of ultrasound (US) and magnetic resonance imaging (MRI) in patients with rheumatoid arthritis (RA)., Methods: Recommendations were generated following a nominal group technique. A panel of experts, consisting of 15 rheumatologists and 3 radiologists, was established in the first panel meeting to define the scope and purpose of the consensus document, as well as chapters, potential recommendations and systematic literature reviews (we used and updated those from previous EULAR documents). A first draft of recommendations and text was generated. Then, an electronic Delphi process (2 rounds) was carried out. Recommendations were voted from 1 (total disagreement) to 10 (total agreement). We defined agreement if at least 70% of experts voted ≥7. The level of evidence and grade or recommendation was assessed using the Oxford Centre for Evidence-based Medicine Levels of Evidence. The full text was circulated and reviewed by the panel. The consensus was coordinated by an expert methodologist., Results: A total of 20 recommendations were proposed. They include the validity of US and MRI regarding inflammation and damage detection, diagnosis, prediction (structural damage progression, flare, treatment response, etc.), monitoring and the use of US guided injections/biopsies., Conclusions: These recommendations will help clinicians use US and MRI in RA patients., (Copyright © 2016 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
25. Immunohistochemical mapping of neurotensin in the alpaca diencephalon.
- Author
-
Sánchez ML, Mangas A, Medina LE, Aguilar LA, Díaz-Cabiale Z, Narváez JA, and Coveñas R
- Subjects
- Animals, Cell Body chemistry, Cell Body metabolism, Diencephalon chemistry, Hypothalamus chemistry, Hypothalamus metabolism, Immunohistochemistry, Male, Neurotensin chemistry, Camelids, New World, Diencephalon metabolism, Neurotensin metabolism
- Abstract
Introduction: The distribution of the immunoreactive cell bodies and fibers containing neurotensin in the alpaca diencephalon was determined by an immunohistochemical technique., Material and Methods: The study was carried out in four male alpacas that lived at sea level. Brains of deeply anesthetized animals were fixed by perfusion with 4% paraformaldehyde. Cryostat sections were stained by a standard immunohistochemical method., Results: Cell bodies containing neurotensin were observed in the zona incerta and hypothalamus. A low/moderate density of these cell bodies was observed in the lateral hypothalamic area, anterior and dorsal hypothalamic areas, suprachiasmatic nucleus, periventricular region of the hypothalamus and in the ventromedial hypothalamic nucleus. In both thalamus and hypothalamus, immunoreactive fibers showed a widespread distribution. In the thalamus, a high density of these fibers was mainly found in the midline nuclei, whereas in the hypothalamus a high density was in general observed in the whole structure., Conclusions: In comparison with other mammals, the thalamus of the alpaca showed the most widespread distribution of neurotensin-immunoreactive fibers. The widespread distribution of neurotensin through the alpaca diencephalon suggests that the peptide can be involved in many physiological actions.
- Published
- 2018
- Full Text
- View/download PDF
26. Clinical and sonographic biomarkers of structural damage progression in RA patients in clinical remission: A prospective study with 12 months follow-up.
- Author
-
Ramírez J, Narváez JA, Ruiz-Esquide V, Hernández-Gañán J, Cuervo A, Inciarte-Mundo J, Hernández MV, Sampayo-Cordero M, Pablos JL, Sanmartí R, and Cañete JD
- Subjects
- Antirheumatic Agents therapeutic use, Arthritis, Rheumatoid blood, Arthritis, Rheumatoid pathology, Biomarkers blood, Blood Sedimentation, Edema pathology, Enzyme-Linked Immunosorbent Assay, Female, Follow-Up Studies, Hand Joints diagnostic imaging, Hand Joints pathology, Humans, Knee Joint diagnostic imaging, Knee Joint pathology, Leukocyte L1 Antigen Complex blood, Male, Middle Aged, Multivariate Analysis, Predictive Value of Tests, Prednisone, Prospective Studies, Remission Induction, Risk Factors, Synovitis blood, Synovitis pathology, Arthritis, Rheumatoid diagnostic imaging, Disease Progression, Edema diagnostic imaging, Magnetic Resonance Imaging methods, Synovitis diagnostic imaging, Ultrasonography methods
- Abstract
Objective: To determine clinical and sonographic biomarkers predicting structural damage progression at 12 months of follow-up as measured by magnetic resonance imaging (MRI) in rheumatoid arthritis (RA) patients in clinical remission., Patients and Methods: We included patients with RA in clinical remission, defined as 28-joint disease activity score (DAS28)-erythrocyte sedimentation rate (ESR) <2.6 for >6 months. Ultrasound scans of both hands and knees and MRI of the dominant hand were performed at baseline and at 12 months., Results: Out of 55 patients, 42 completed the follow-up. Among them, 78% were female, aged (median) 54 years; disease duration was 93 months. In total, 12 (28%) patients were taking oral prednisone, 34 (81%) conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), and 20 (47%) biological therapies. At baseline, 45% fulfilled criteria previously defined for ultrasound-defined active synovitis (UdAS) [PD (power Doppler) signal + synovial hyperplasia ≥2]. Multivariate analysis showed significant associations between baseline MRI erosion score, body mass index (BMI), disease duration, prednisone treatment, absence of biologic and csDMARDs, UdAS, and MRI erosion score progression after 12 months. In an exploratory analysis, serum levels of calprotectin correlated significantly with bone edema progression., Conclusions: We identified clinical and sonographic markers of structural damage progression after 12 months follow-up in patients with RA in clinical remission. Meeting the criteria of ultrasound active synovitis, defined as simultaneous relevant synovial hyperplasia and PD, was associated with erosion progression after 12 months. Calprotectin was associated with bone edema, in an exploratory analysis., (Copyright © 2017 Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
27. Galanin (1-15) enhancement of the behavioral effects of Fluoxetine in the forced swimming test gives a new therapeutic strategy against depression.
- Author
-
Flores-Burgess A, Millón C, Gago B, Narváez M, Borroto-Escuela DO, Mengod G, Narváez JA, Fuxe K, Santín L, and Díaz-Cabiale Z
- Subjects
- Animals, Autoradiography, Cyclohexanes therapeutic use, Disease Models, Animal, Dose-Response Relationship, Drug, Drug Delivery Systems, Drug Therapy, Combination, Hippocampus drug effects, Hippocampus metabolism, Immobility Response, Tonic drug effects, Male, Piperazines therapeutic use, RNA, Small Interfering metabolism, Rats, Rats, Sprague-Dawley, Receptor, Galanin, Type 1 genetics, Receptor, Galanin, Type 1 metabolism, Receptor, Galanin, Type 2 genetics, Receptor, Galanin, Type 2 metabolism, Statistics, Nonparametric, Antidepressive Agents therapeutic use, Depression drug therapy, Depression physiopathology, Fluoxetine therapeutic use, Galanin therapeutic use, Peptide Fragments therapeutic use, Swimming psychology
- Abstract
The pharmacological treatment of major depression is mainly based on drugs elevating serotonergic (5-HT) activity. Specifically, selective 5-HT reuptake inhibitors, including Fluoxetine (FLX), are the most commonly used for treatment of major depression. However, the understanding of the mechanism of action of FLX beyond its effect of elevating 5-HT is limited. The interaction between serotoninergic system and neuropeptides signaling could be a key aspect. We examined the ability of the neuropeptide Galanin(1-15) [GAL(1-15)] to modulate the behavioral effects of FLX in the forced swimming test (FST) and studied feasible molecular mechanisms. The data show that GAL(1-15) enhances the antidepressant-like effects induced by FLX in the FST, and we demonstrate the involvement of GALR1/GALR2 heteroreceptor complex in the GAL(1-15)-mediated effect using in vivo rat models for siRNA GALR1 or GALR2 knockdown. Importantly, 5-HT1A receptors (5HT1A-R) also participate in the GAL(1-15)/FLX interactions since the 5HT1AR antagonist WAY100635 blocked the behavioral effects in the FST induced by the coadministration of GAL(1-15) and FLX. The mechanism underlying GAL(1-15)/FLX interactions affected the binding characteristics as well as the mRNA levels of 5-HT1A-R specifically in the dorsal hippocampus while leaving unaffected mRNA levels and affinity and binding sites of this receptor in the dorsal raphe. The results open up the possibility to use GAL(1-15) as for a combination therapy with FLX as a novel strategy for treatment of depression., (Copyright © 2017 Elsevier Ltd. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
28. Mapping of enkephalins and adrenocorticotropic hormone in the squirrel monkey brainstem.
- Author
-
Duque-Díaz E, Díaz-Cabiale Z, Narváez JA, and Coveñas R
- Subjects
- Animals, Immunohistochemistry, Male, Saimiri, Adrenocorticotropic Hormone metabolism, Brain Stem metabolism, Enkephalins metabolism
- Abstract
An immunocytochemical technique has been used to study for the first time the distribution of fibers and cell bodies containing leucine-enkephalin (leu-enk), methionine-enkephalin (met-enk) or adrenocorticotropic hormone (ACTH) in the whole brainstem of the squirrel monkey Saimiri sciureus. Cell bodies containing leu-enk or met-enk were found in the superior colliculus and the formatio reticularis tegmenti mesencephali, respectively. No immunoreactive cell bodies containing ACTH were observed. Leu-enk-immunoreactive fibers were observed in 40 brainstem nuclei/tracts/regions, fibers containing met-enk were found in 38 brainstem nuclei/tracts/regions and fibers containing ACTH were found in 26 nuclei/tracts/regions. In the latter case, the density of immunoreactive fibers was always low. A high/moderate density of leu-enk- or met-enk-immunoreactive fibers were found in 18 and 16 brainstem nuclei/tracts/regions, respectively. The distribution of immunoreactive fibers containing leu-enk or met-enk was quite similar, with both leu-enk and met-enk observed in 82.5 % of the squirrel monkey brainstem nuclei/tracts/regions. This relationship is less marked for met-enk and ACTH (60.5 %) and even lower for leu-enk and ACTH (52.5 %). In 42.5 % of the nuclei/tracts/regions of the squirrel monkey brainstem (colliculus superior, substantia grisea centralis, nucleus interpeduncularis, nucleus tractus spinalis nervi trigemini, nucleus tractus solitarii, nucleus parabrachialis, formatio reticularis, substantia nigra), we observed fibers containing all three neuropeptides. The widespread distribution reported here suggests that enkephalins and ACTH can be involved in several physiological functions. The distribution of the immunoreactive fibers reported here is quite similar to that previously reported for enkephalins and ACTH in Macaca species and humans.
- Published
- 2017
- Full Text
- View/download PDF
29. Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis.
- Author
-
Gómez-Vaquero C, Martín I, Loza E, Carmona L, Ivorra J, Narváez JA, Hernández-Gañán J, Alía P, and Narváez J
- Subjects
- Adult, Aged, Biomarkers blood, Female, Follow-Up Studies, Humans, Joints metabolism, Longitudinal Studies, Male, Middle Aged, Prospective Studies, Arthritis, Rheumatoid blood, Arthritis, Rheumatoid diagnostic imaging, Arthritis, Rheumatoid therapy, Intercellular Signaling Peptides and Proteins blood, Joints diagnostic imaging, Osteoprotegerin blood
- Abstract
Objective: To analyze the association between circulating osteoprotegerin (OPG) and Dickkopf-related protein 1 (DKK-1) and radiological progression in patients with tightly controlled rheumatoid arthritis (RA)., Methods: Serum levels of OPG and DKK-1 were measured in 97 RA patients who were treated according to a treat-to-target strategy (T2T) aimed at remission (DAS28<2.6). Radiologic joint damage progression was assessed by changes in the total Sharp-van der Heijde score (SHS) on serial radiographs of the hands and feet. The independent association between these biomarker levels and the structural damage endpoint was examined using regression analysis., Results: The mean age of the 97 RA patients (68 women) at the time of the study was 54 ± 14 years, and the median disease duration was 1.6 ± 1.5 years. Most patients were seropositive for either RF or ACPA, and the large majority (76%) were in remission or had low disease activity. After a median follow-up time of 3.3 ± 1.5 years (range, 1-7.5 yrs.), the mean total SHS annual progression was 0.88 ± 2.20 units. Fifty-two percent of the patients had no progression (defined as a total SHS of zero). The mean serum OPG level did not change significantly over the study period (from 3.9 ± 1.8 to 4.07 ± 2.23 pmol/L), whereas the mean serum DKK-1 level decreased, although not significantly (from 29.9 ± 10.9 to 23.6 ± 18.8 pmol/L). In the multivariate analysis, the predictive factors increasing the likelihood of total SHS progression were age (OR per year = 1.10; p = 0.003) and a high mean C-reactive protein level over the study period (OR = 1.29; p = 0.005). Circulating OPG showed a protective effect reducing the likelihood of joint space narrowing by 60% (95% CI: 0.38-0.94) and the total SHS progression by 48% (95% CI: 0.28-0.83). The DKK-1 levels were not associated with radiological progression., Conclusion: In patients with tightly controlled RA, serum OPG was inversely associated with progression of joint destruction. This biomarker may be useful in combination with other risk factors to improve prediction in patients in clinical remission or low disease activity state., Competing Interests: The authors have declared that no competing interests exists.
- Published
- 2016
- Full Text
- View/download PDF
30. Galanin (1-15) enhances the antidepressant effects of the 5-HT1A receptor agonist 8-OH-DPAT: involvement of the raphe-hippocampal 5-HT neuron system.
- Author
-
Millón C, Flores-Burgess A, Narváez M, Borroto-Escuela DO, Santín L, Gago B, Narváez JA, Fuxe K, and Díaz-Cabiale Z
- Subjects
- 8-Hydroxy-2-(di-n-propylamino)tetralin pharmacology, Animals, Antidepressive Agents pharmacology, Behavior, Animal drug effects, Behavior, Animal physiology, Dorsal Raphe Nucleus metabolism, Galanin pharmacology, Hippocampus metabolism, Male, Peptide Fragments pharmacology, Peptides administration & dosage, RNA, Messenger metabolism, Rats, Rats, Sprague-Dawley, Receptor, Galanin, Type 1 metabolism, Receptor, Galanin, Type 2 antagonists & inhibitors, Receptor, Galanin, Type 2 metabolism, Serotonergic Neurons metabolism, Serotonin Receptor Agonists pharmacology, 8-Hydroxy-2-(di-n-propylamino)tetralin administration & dosage, Antidepressive Agents administration & dosage, Dorsal Raphe Nucleus drug effects, Galanin administration & dosage, Hippocampus drug effects, Peptide Fragments administration & dosage, Serotonergic Neurons drug effects, Serotonin Receptor Agonists administration & dosage
- Abstract
Galanin N-terminal fragment (1-15) [GAL(1-15)] is associated with depression-related and anxiogenic-like effects in rats. In this study, we analyzed the ability of GAL(1-15) to modulate 5-HT1A receptors (5-HT1AR), a key receptor in depression. GAL(1-15) enhanced the antidepressant effects induced by the 5-HT1AR agonist 8-OH-DPAT in the forced swimming test. These effects were stronger than the ones induced by Galanin (GAL). This action involved interactions at receptor level since GAL(1-15) affected the binding characteristics and the mRNA levels of 5-HT1AR in the dorsal hippocampus and dorsal raphe. The involvement of the GALR2 was demonstrated with the GALR2 antagonist M871. Proximity ligation assay experiments indicated that 5-HT1AR are in close proximity with GALR1 and GALR2 in both regions and in raphe RN33B cells. The current results indicate that GAL(1-15) enhances the antidepressant effects induced by 8-OH-DPAT acting on 5-HT1AR operating as postjunctional or as autoreceptors. These results may give the basis for the development of drugs targeting potential GALR1-GALR2-5-HT1AR heteroreceptor complexes linked to the raphe-hippocampal 5-HT neurons for the treatment of depression.
- Published
- 2016
- Full Text
- View/download PDF
31. Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the dentate gyrus are related with antidepressant-like effects.
- Author
-
Narváez M, Borroto-Escuela DO, Millón C, Gago B, Flores-Burgess A, Santín L, Fuxe K, Narváez JA, and Díaz-Cabiale Z
- Subjects
- Animals, Galanin administration & dosage, Male, Neurons metabolism, RNA, Messenger metabolism, Rats, Rats, Sprague-Dawley, Receptor, Galanin, Type 2 agonists, Dentate Gyrus metabolism, Depression metabolism, Receptor, Galanin, Type 2 metabolism, Receptors, Neuropeptide Y metabolism
- Abstract
Galanin (GAL) and the NPYY1 agonist play a role in mood regulation and both neuropeptides interact in several central functions. The present study examined the interaction between Galanin receptor 2 (GALR2) and Neuropeptide Y Y1 receptor (NPYY1R) in the dentate gyrus (DG) of the Hippocampus in relation to depression-like behavior. Using receptor autoradiography, in situ hybridization and in situ proximity ligation assay an interaction between GALR and NPYY1R was demonstrated in the DG probably involving the formation of GALR2-NPYY1R heteroreceptor complexes. These complexes were specifically observed in the polymorphic and subgranular subregions of the DG, where both receptors were found to colocalize. Moreover, this GALR2/NPYY1R interaction was linked to an enhancement of the antidepressive-like behavior mediated by NPYY1R in the forced swimming test. Specific cells populations within DG subregions may be involved in this behavioral effect since the coactivation of GALR2 and NPYY1R enhances the NPYY1R-mediated reduction in the number of c-Fos immunoreactive nuclei in the polymorphic region. These results indicate that GALR2/NPYY1R interactions can provide a novel integrative mechanism in DG in depression-related behavior and may give the basis for the development of drugs targeting GALR2/NPYY1R heteroreceptor complexes in the DG of the hippocampus for the treatment of depression.
- Published
- 2016
- Full Text
- View/download PDF
32. Mapping of methionine-enkephalin-arg 6 -gly 7 -leu 8 in the human diencephalon.
- Author
-
Sánchez ML, Díaz-Cabiale Z, Narváez JA, Manso B, Salinas P, Rivada E, Smith V, and Coveñas R
- Subjects
- Aged, 80 and over, Enkephalin, Methionine metabolism, Enkephalins metabolism, Female, Humans, Immunohistochemistry, Male, Protein Precursors metabolism, Diencephalon cytology, Diencephalon metabolism, Enkephalin, Methionine analogs & derivatives
- Abstract
Using an immunohistochemical technique, we mapped the immunoreactive structures containing methionine-enkephalin-Arg
6 -Gly7 -Leu8 (Met-8) (a marker for the pro-enkephalin system) in the human diencephalon. Compared with previous studies, we observed a more widespread distribution of Met-8 in the human diencephalon. Met-8-immunoreactive cell bodies and fibers exhibited a more widespread distribution in the hypothalamus than in the thalamus. We observed six populations of Met-8-immunoreactive cell bodies. These perikarya were observed in the paratenial thalamic nucleus, ventromedial and dorsomedial hypothalamic nuclei, lateral hypothalamic area, pallidohypothalamic nucleus and in the paraventricular hypothalamic nucleus (posterior part). In the thalamus, Met-8-immunoreactive fibers were primarily observed in the midline region, whereas in the hypothalamus, these fibers were widely distributed. In general, a moderate/low density of Met-8-immunoreactive fibers was observed in the diencephalic nuclei. A moderate density was observed in the paraventricular thalamic nucleus, reuniens thalamic nucleus, lateral and medial geniculate nuclei, dorsomedial hypothalamic nucleus, paraventricular hypothalamic nucleus (posterior part) and ventromedial hypothalamic nucleus. The present study is the first to demonstrate the presence of clusters of Met-8-immunoreactive cell bodies in the human thalamus and hypothalamus, the distribution of fibers containing neuropeptides in the hypothalamus and the presence of these fibers in several thalamic nuclei. This neuroanatomical study will serve to elucidate the physiological roles of Met-8 in future studies of the human diencephalon., (Copyright © 2016 IBRO. Published by Elsevier Ltd. All rights reserved.)- Published
- 2016
- Full Text
- View/download PDF
33. Rheumatic diseases of the spine: imaging diagnosis.
- Author
-
Narváez JA, Hernández-Gañán J, Isern J, and Sánchez-Fernández JJ
- Subjects
- Arthritis, Rheumatoid complications, Humans, Magnetic Resonance Imaging, Radiography, Spondylarthritis complications, Arthritis, Rheumatoid diagnostic imaging, Cervical Vertebrae diagnostic imaging, Spondylarthritis diagnostic imaging
- Abstract
Spinal involvement is common both in the spondyloarthritides and in rheumatoid arthritis, in which the cervical segment is selectively affected. Rheumatoid involvement of the cervical spine has characteristic radiologic manifestations, fundamentally different patterns of atlantoaxial instability. Magnetic resonance imaging (MRI) is the technique of choice for evaluating the possible repercussions of atlantoaxial instability on the spinal cord and/or nerve roots in patients with rheumatoid arthritis as well as for evaluating parameters indicative of active inflammation, such as bone edema and synovitis. Axial involvement is characteristic in the spondyloarthritides and has distinctive manifestations on plain-film X-rays, which reflect destructive and reparative phenomena. The use of MRI has changed the conception of spondyloarthritis because it is able to directly detect the inflammatory changes that form part of the disease, making it possible to establish the diagnosis early in the disease process, when plain-film X-ray findings are normal (non-radiographic axial spondyloarthritis), to assess the prognosis of the disease, and to contribute to treatment planning., (Copyright © 2016 SERAM. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
34. Risk factors and prognosis of vertebral compressive fracture in pyogenic vertebral osteomyelitis.
- Author
-
Ribera A, Labori M, Hernández J, Lora-Tamayo J, González-Cañas L, Font F, Nolla JM, Ariza J, Narváez JA, and Murillo O
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Prognosis, Retrospective Studies, Risk Factors, Osteomyelitis complications, Osteomyelitis pathology, Spinal Fractures epidemiology, Spinal Fractures pathology
- Abstract
Objectives: To analyse the clinical, microbiological and radiological characteristics, and to identify risk factors of vertebral compressive fracture (VF) in spontaneous pyogenic vertebral osteomyelitis (VO)., Methods: A retrospective clinical study and blinded radiological review of adult patients with VO., Results: Eighty-eight patients were included: 57 (65%) had a definitive diagnosis of VO (positive microbiology), and 31 (35%) had a probable diagnosis of VO. Of these, 27 (30.7%) presented with VF at diagnosis of VO, and 4 afterwards (total 31, 35.2%). Patients with VF were considered to be at higher risk of osteopenia--they were older (74 vs 66 years, p = 0.013), and included high percentage of women (33 vs 41%, NS)--; and presented more dorsal involvement (56 vs 21%; p < 0.007). Causal microorganisms were similar between groups (VF, no VF). The time to diagnosis of VO was longer in the presence of VF (65 vs 23 days, p = 0.001), and also in cases with no isolated organisms. All patients received antibiotics, and just one patient required spinal stabilisation (VF). After 357 median days of follow-up, all patients were cured. Clinical improvement (residual pain, functional recovery) tended to be slower in patients with VF (log-rank 0.19 and 0.15, respectively), but clinical symptoms were similar in most patients at the last follow-up (VF, no VF)., Conclusions: VF is a common complication in pyogenic VO that causes slower clinical recovery. Risk factors of VF are: osteopenia, a delayed diagnosis and dorsal involvement. Conservative management is probably appropriate for most cases, but spinal stabilisation should be considered in some specific cases.
- Published
- 2016
- Full Text
- View/download PDF
35. Guidelines for magnetic resonance imaging in axial spondyloarthritis: A Delphi study.
- Author
-
Narváez JA, Bueno Horcajadas A, de Miguel Mendieta E, and Sanz Sanz J
- Subjects
- Delphi Technique, Early Diagnosis, Humans, Practice Guidelines as Topic, Prognosis, Magnetic Resonance Imaging, Spondylarthritis diagnostic imaging
- Abstract
Objective: The term axial spondyloarthritis refers to a group of chronic inflammatory rheumatic diseases with a common genetic basis that course with axial and peripheral involvement and enthesitis. Recently, the Assessment of SpondyloArthritis international Society (ASAS) established some diagnostic criteria, including for the first time magnetic resonance imaging (MRI) findings. Given the difficulties of obtaining MRI in some environments and the lack of experience with axial spondyloarthritis, a group of radiologists and rheumatologists sought to establish some practical guidelines to ensure the correct use of MRI in this disease., Material and Methods: Using the Delphi method, we used a questionnaire with 49 items stratified into 4 blocks to survey 46 experts in the MRI diagnosis of axial spondyloarthritis., Results: The experts agreed on 82% of the items. The degree of agreement was 100% in the block "Importance of early diagnosis of axial spondyloarthritis", 69% in the block "Optimization of the use of MRI in the diagnosis of axial spondyloarthritis", 93% in the block "Use of MRI in axial spondyloarthritis: Technical aspects", and 57% in the block "Usefulness of MRI in the prognosis, follow-up, and evaluation of the response to treatment in axial spondyloarthritis"., Conclusions: Despite the importance of MRI in the early diagnosis of axial spondyloarthritis, this study shows the need for standardization and points to relative disagreement about how to use MRI in the follow-up of the disease and evaluation of the response to treatment. The results of this study can help improve the use of MRI in axial spondyloarthritis., (Copyright © 2014 SERAM. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
36. Subaxial cervical spine involvement in symptomatic rheumatoid arthritis patients: Comparison with cervical spondylosis.
- Author
-
Narváez J, Narváez JA, Serrallonga M, de Lama E, Hernández-Gañan J, Gómez-Vaquero C, and Nolla JM
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Spinal Stenosis pathology, Young Adult, Arthritis, Rheumatoid pathology, Cervical Vertebrae pathology, Spinal Cord Compression pathology, Spondylosis pathology
- Abstract
Objective: To investigate the frequency, location, characteristics, and clinical significance of subaxial involvement (below C1-C2) in a series of patients with rheumatoid arthritis (RA) and symptomatic involvement of the cervical spine., Methods: A total of 41 patients with RA were examined via cervical spine magnetic resonance imaging (MRI). A comparative analysis of the incidence of the different types of subaxial lesions was performed between these patients and 41 age- and sex-matched patients with symptomatic cervical spondylosis., Results: Stenosis of the spinal canal was found at the subaxial level in 85% of RA patients, and at the atlantoaxial level in 44%. Comparative analysis between these patients and the cervical spondylosis patients revealed significant differences in the types and frequencies of subaxial lesions. For both conditions, signs of discopathy and end-plate osteophytosis were the most common abnormalities observed on magnetic resonance imaging (MRI). However, in the RA patients these abnormalities coincided with subchondral bone and ligamentous acute inflammatory changes and with secondary destruction (vertebral instability) or repair (vertebral ankyloses). Only evidence of subaxial myelopathy was significantly associated with an increased risk of neurological dysfunction among the RA patients [Ranawat class II or III; P = 0.01; odds ratio (OR) = 11.43], although subaxial cord compression tended toward a significant association with the risk of neurological dysfunction (P = 0.06; OR = 3.95)., Conclusion: Subaxial stenosis seems to be the consequence of both the inflammatory process and mechanical-degenerative changes. Despite its frequency, it was not usually related to the occurrence of myelopathy symptoms, not even in cases with MRI evidence of spinal cord compression., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
37. Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the amygdala lead to increased anxiolytic actions.
- Author
-
Narváez M, Millón C, Borroto-Escuela D, Flores-Burgess A, Santín L, Parrado C, Gago B, Puigcerver A, Fuxe K, Narváez JA, and Díaz-Cabiale Z
- Subjects
- Amygdala drug effects, Animals, Autoradiography, Bradykinin analogs & derivatives, Bradykinin pharmacology, Drug Administration Routes, Drug Interactions, Exploratory Behavior drug effects, Galanin pharmacology, Green Fluorescent Proteins genetics, Green Fluorescent Proteins metabolism, HEK293 Cells, Humans, Male, Maze Learning drug effects, Neuropeptide Y analogs & derivatives, Neuropeptide Y pharmacology, Peptide Fragments pharmacology, Peptides pharmacology, Protein Binding drug effects, Proto-Oncogene Proteins c-fos metabolism, Rats, Rats, Sprague-Dawley, Receptor, Galanin, Type 2 genetics, Receptors, Neuropeptide Y genetics, Statistics, Nonparametric, Transfection, Amygdala metabolism, Receptor, Galanin, Type 2 metabolism, Receptors, Neuropeptide Y metabolism
- Abstract
Galanin (GAL) and neuropeptide Y (NPY) are neuropeptides involved in behaviors associated with anxiety. Both neuropeptides interact in several central functions. However, the potential behavioral and cellular interactions between them in anxiety are unknown. GAL was found to act through GAL receptor 2 (GALR2) to enhance NPYY1 receptor (NPYY1R)-mediated anxiolytic behaviors in rats. Using receptor autoradiography, c-Fos expression and in situ proximity ligation assay, the medial paracapsular intercalated nuclei of the amygdala were determined to be a key area in the interaction probably involving the formation of GALR2/NPYY1R heteroreceptor complexes. In cell cultures costimulation of GALR2 and NPYY1R induced changes in the functions of these receptors. The changes involved a potentiation of the decrease in the phosphorylation of CREB induced by NPYY1R and a delay in the internalization of NPYY1R. These results indicate that GALR2/NPYY1R interactions can provide a novel integrative amygdaloid mechanism in anxiety.
- Published
- 2015
- Full Text
- View/download PDF
38. A role for galanin N-terminal fragment (1-15) in anxiety- and depression-related behaviors in rats.
- Author
-
Millón C, Flores-Burgess A, Narváez M, Borroto-Escuela DO, Santín L, Parrado C, Narváez JA, Fuxe K, and Díaz-Cabiale Z
- Subjects
- Animals, Cell Line, Transformed, Dark Adaptation drug effects, Dose-Response Relationship, Drug, Exploratory Behavior drug effects, Galanin antagonists & inhibitors, Gene Expression Regulation drug effects, Hippocampus drug effects, Hippocampus metabolism, Male, Peptide Fragments toxicity, Raphe Nuclei drug effects, Raphe Nuclei metabolism, Rats, Rats, Sprague-Dawley, Rats, Transgenic, Receptor, Galanin, Type 1 deficiency, Receptor, Galanin, Type 1 genetics, Receptor, Galanin, Type 2 deficiency, Receptor, Galanin, Type 2 genetics, Serotonin metabolism, Time Factors, Anxiety chemically induced, Depression chemically induced, Galanin chemistry, Galanin toxicity
- Abstract
Background: Galanin (GAL) plays a role in mood regulation. In this study we analyzed the action of the active N-terminal fragment [GAL(1-15)] in anxiety- and depression-related behavioral tests in rats., Methods: The effect of GAL(1-15) was analyzed in the forced swimming test, tail suspension test, open field test, and light/dark test. The proximity of GAL1 and GAL2 receptors was examined with the proximity ligation assay (PLA). We tested the GAL receptors involved in GAL(1-15) effects with the GAL2 receptor antagonist M871 and with an in vivo model of siRNA GAL2 receptor knockdown or siRNA GAL1 receptor knockdown rats. The effects of GAL(1-15) were also studied in the cell line RN33B., Results: GAL(1-15) induced strong depression-like and anxiogenic-like effects in all the tests. These effects were stronger than the ones induced by GAL. The involvement of the GAL2 receptor was demonstrated with M871 and with the siRNA GAL2 receptor knockdown rats. The PLA indicated the possible existence of GAL1 and GAL2 heteroreceptor complexes in the dorsal hippocampus and especially in the dorsal raphe nucleus. In the siRNA GAL1 receptor knockdown rats the behavioral actions of GAL(1-15) disappeared, and in the siRNA GAL2 receptor knockdown rats the reductions of the behavioral actions of GAL(1-15) was linked to a disappearance of PLA. In the cell line RN33B, GAL(1-15) decreased 5-HT immunoreactivity more strongly than GAL., Conclusions: Our results indicate that GAL(1-15) exerts strong depression-related and anxiogenic-like effects and may give the basis for the development of drugs targeting GAL1 and GAL2 heteroreceptor complexes in the raphe-limbic system for the treatment of depression and anxiety., (© The Author 2015. Published by Oxford University Press on behalf of CINP.)
- Published
- 2014
- Full Text
- View/download PDF
39. Immunohistochemical mapping of pro-opiomelanocortin- and pro-dynorphin-derived peptides in the alpaca (Lama pacos) diencephalon.
- Author
-
Manso B, Sánchez ML, Medina LE, Aguilar LA, Díaz-Cabiale Z, Narváez JA, and Coveñas R
- Subjects
- Animals, Camelids, New World, Enkephalins metabolism, Immunohistochemistry, Male, Neurons metabolism, Pro-Opiomelanocortin metabolism, Protein Precursors metabolism, Brain Chemistry, Diencephalon, Enkephalins analysis, Pro-Opiomelanocortin analysis, Protein Precursors analysis
- Abstract
Using an indirect immunoperoxidase technique, we studied the distribution of cell bodies and fibres containing non-opioid peptides (adrenocorticotropin hormone (ACTH), alpha-melanocyte-stimulating hormone) and opioid peptides (beta-endorphin (1-27), alpha-neo-endorphin, leucine-enkephalin) in the alpaca diencephalon. No immunoreactive cell bodies containing ACTH were found. Perikarya containing the other four peptides were observed exclusively in the hypothalamus and their distribution was restricted. Perikarya containing alpha-melanocyte-stimulating hormone or alpha-neo-endorphin showed a more widespread distribution than those containing leucine-enkephalin or beta-endorphin (1-27). Cell bodies containing pro-opiomelanocortin-derived peptides were observed in the arcuate nucleus, anterior and lateral hypothalamic areas and in the ventromedial and supraoptic hypothalamic nuclei, whereas perikarya containing alpha-neo-endorphin (a pro-dynorphin-derived peptide) were found in the arcuate nucleus, dorsal and lateral hypothalamic areas, and in the paraventricular, ventromedial and supraoptic hypothalamic nuclei. Immunoreactive cell bodies containing leucine-enkephalin were found in the lateral hypothalamic area and in the paraventricular hypothalamic nucleus. Immunoreactive fibres expressing pro-opiomelanocortin-derived peptides were more numerous than those expressing pro-dynorphin-derived peptides. A close anatomical relationship was observed: in all the diencephalic nuclei in which beta-endorphin (1-27)-immunoreactive fibres were found, fibres containing alpha-melanocyte-stimulating hormone or alpha-neo-endorphin were also observed. Fibres containing beta-endorphin (1-27), alpha-melanocyte-stimulating hormone or alpha-neo-endorphin were widely distributed throughout the diencephalon, but fibres containing ACTH or leucine-enkephalin showed a moderate distribution. The distribution of the five peptides studied here is also compared with that reported previously in other mammalian species. The widespread distribution observed indicates that both the pro-dynorphin and the pro-opiomelanocortin systems are involved in multiple physiological actions (e.g., food intake, thermoregulation, neuroendocrine and reproductive mechanisms) in the alpaca diencephalon., (Copyright © 2014 Elsevier B.V. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
40. Mapping of neurotensin in the alpaca (Lama pacos) brainstem.
- Author
-
de Souza E, Aguilar LA, Díaz-Cabiale Z, Narváez JA, and Coveñas R
- Subjects
- Animals, Cell Body, Male, Nerve Fibers, Tissue Distribution, Brain Stem metabolism, Camelids, New World metabolism, Neurotensin metabolism
- Abstract
We studied the distribution of cell bodies and fibres containing neurotensin (NT) in the brainstem of the alpaca using an indirect immunoperoxidase technique. Immunoreactive fibres were widely distributed throughout the brainstem, whereas the distribution of cell bodies was less widespread. Immunoreactive perikarya were only found in the mesencephalic and bulbar reticular formation, periaqueductal grey, nucleus of the solitary tract, laminar spinal trigeminal nucleus and in the inferior colliculus. A high density of fibres containing NT was found in the dorsal nucleus of the raphe, marginal nucleus of the brachium conjunctivum, locus coeruleus, inferior colliculus, inter-peduncular nucleus, substantia nigra, periaqueductal grey, reticular formation of the mesencephalon, pons and medulla oblongata, nucleus of the solitary tract, laminar spinal trigeminal nucleus, hypoglossal nucleus, inferior central nucleus and in the tegmental reticular nucleus. The widespread distribution indicates that NT might be involved in multiple physiological actions in the alpaca brainstem; this must be investigated in the future as alpacas lives from 0 m above sea level to altitudes of up 5000 m and hence the involvement of this neuropeptide in special and unique regulatory physiological mechanisms could be suggested., (© 2013 Blackwell Verlag GmbH.)
- Published
- 2014
- Full Text
- View/download PDF
41. Galanin receptor/neuropeptide y receptor interactions in the central nervous system.
- Author
-
Díaz-Cabiale Z, Flores-Burgess A, Parrado C, Narváez M, Millón C, Puigcerver A, Coveñas R, Fuxe K, and Narváez JA
- Subjects
- Animals, Galanin metabolism, Humans, Neuropeptide Y metabolism, Peptide Fragments metabolism, Central Nervous System metabolism, Receptors, Galanin metabolism, Receptors, Neuropeptide Y metabolism
- Abstract
The presence of Galanin and Neuropeptide Y and/or their receptors in several areas of the brain involved in memory, mood, cardiovascular control and food intake indicates that Galanin, and Neuropeptide Y could equilibrate the physiological actions of each other. There is evidence for the existence of interactions between Galanin Receptor and Neuropeptide Y Receptor in the nucleus of the solitarii tract (NTS), hypothalamus and dorsal raphe nucleus probably taking place with the formation of heteromers between Galanin Receptor and Neuropeptide Y Y1 Receptor. The galanin fragment (Gal 1-15) preferring receptors may instead be formed by the GalR1-GalR2 heteromer which in the NTS may interact with Neuropeptide Y Y2 receptors. These receptor heteromers may be one key molecular mechanism for Galanin and its N-terminal fragment (Galanin 1-15) to modulate the function of different types of glia-neuronal networks in the CNS, especially the emotional, metabolic and cardiovascular networks.
- Published
- 2014
- Full Text
- View/download PDF
42. Lack of response to teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw.
- Author
-
Narváez J, Narváez JA, Gómez-Vaquero C, and Nolla JM
- Subjects
- Aged, Female, Humans, Treatment Failure, Bisphosphonate-Associated Osteonecrosis of the Jaw drug therapy, Bone Density Conservation Agents therapeutic use, Teriparatide therapeutic use
- Published
- 2013
- Full Text
- View/download PDF
43. Mapping of alpha-neo-endorphin- and neurokinin B-immunoreactivity in the human brainstem.
- Author
-
Duque E, Mangas A, Salinas P, Díaz-Cabiale Z, Narváez JA, and Coveñas R
- Subjects
- Aged, Aged, 80 and over, Autopsy, Biomarkers analysis, Brain Stem cytology, Female, Humans, Male, Brain Stem chemistry, Endorphins analysis, Immunohistochemistry, Nerve Fibers chemistry, Neurokinin B analysis, Protein Precursors analysis
- Abstract
We have studied the distribution of alpha-neo-endorphin- or neurokinin B-immunoreactive fibres and cell bodies in the adult human brainstem with no prior history of neurological or psychiatric disease. A low density of alpha-neo-endorphin-immunoreactive cell bodies was only observed in the medullary central gray matter and in the spinal trigeminal nucleus (gelatinosa part). Alpha-neo-endorphin-immunoreactive fibres were moderately distributed throughout the human brainstem. A high density of alpha-neo-endorphin-immunoreactive fibres was found only in the solitary nucleus (caudal part), in the spinal trigeminal nucleus (caudal part), and in the gelatinosa part of the latter nucleus. Neurokinin B-immunoreactive cell bodies (low density) were found in the periventricular central gray matter, the reticular formation of the pons and in the superior colliculus. The distribution of the neurokinin-immunoreactive fibres was restricted. In general, for both neuropeptides the density of the immunoreactive fibres was low. In the human brainstem, the proenkephalin system was more widely distributed than the prodynorphin system, and the preprotachykinin A system (neurokinin A) was more widely distributed than the preprotachykinin B system (neurokinin B).
- Published
- 2013
- Full Text
- View/download PDF
44. Can magnetic resonance imaging of the hand and wrist differentiate between rheumatoid arthritis and psoriatic arthritis in the early stages of the disease?
- Author
-
Narváez J, Narváez JA, de Albert M, Gómez-Vaquero C, and Nolla JM
- Subjects
- Arthritis, Psoriatic complications, Arthritis, Rheumatoid complications, Contrast Media, Diagnosis, Differential, Early Diagnosis, Edema diagnosis, Edema etiology, Female, Humans, Male, Middle Aged, Patient Selection, Prospective Studies, Synovitis diagnosis, Synovitis etiology, Tendinopathy diagnosis, Tendinopathy etiology, Arthritis, Psoriatic diagnosis, Arthritis, Rheumatoid diagnosis, Magnetic Resonance Imaging methods, Wrist Joint pathology
- Abstract
Objective: To investigate whether rheumatoid arthritis (RA) and psoriatic arthritis (PsA) can be differentiated in the early stages of the disease (duration of symptoms ≤1 year) on the basis of magnetic resonance imaging (MRI) features of the hand and wrist., Material and Methods: Twenty early RA and 17 early PsA patients with symptomatic involvement of the wrist and hand joints and inconclusive radiographic studies were examined prospectively with contrast-enhanced MRI. Images were evaluated in accordance with the Outcome Measures in Rheumatology Clinical Trials recommendations., Results: Certain MRI features, such as the presence of enthesitis or extensive diaphyseal bone marrow edema, were observed exclusively in PsA (P = 0.0001). These distinctive findings were present in nearly 71% (12/17) of PsA patients. Diffuse and, in some cases, pronounced soft-tissue edema spreading to the subcutis was also seen more frequently in patients with PsA (P = 0.002). There were no significant differences in the frequency of synovitis, bone erosions, subchondral bone edema, or tenosynovitis between the 2 groups. However, in RA extensor tendons were involved more often than the flexor tendons, whereas in PsA the opposite was observed (P = 0.014). With respect to the discriminatory power of the different MRI findings examined, only the presence of enthesitis or diaphyseal bone edema and, to a lesser extent, the pattern of hand tendon involvement and the presence of soft-tissue edema accurately differentiated PsA from RA (all these features achieved accuracies greater than 0.70)., Conclusions: We observed significant differences in the MRI findings of the hand and wrist that can help to distinguish between RA and PsA in the early stages of disease. This imaging method could help to assist in the differential diagnostic process in selected patients in whom diagnosis cannot be unequivocally established after conventional clinical, biochemical, and radiographic examinations., (Copyright © 2012 Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
45. Mapping of CGRP in the alpaca diencephalon.
- Author
-
Coveñas R, Sánchez ML, Mangas A, Medina LE, Aguilar LA, Díaz-Cabiale Z, and Narváez JA
- Subjects
- Animals, Immunohistochemistry, Male, Calcitonin Gene-Related Peptide analysis, Calcitonin Gene-Related Peptide blood, Camelids, New World metabolism, Diencephalon metabolism
- Abstract
We report the distribution of immunoreactive cell bodies and fibers containing calcitonin gene-related peptide in the alpaca diencephalon. This study was carried out in alpacas that lived from birth to death at 0 m above sea level. Immunoreactive fibers were widely distributed throughout the thalamus and hypothalamus. A moderate density of these fibers was found in the zona incerta, the central medial, subparafascicular, reuniens and rhomboid thalamic nuclei, in the preoptic, anterior, lateral and dorsal hypothalamic areas, around the fornix, in the posterior, ventromedial and paraventricular hypothalamic nuclei and in the lateral mammillary nucleus. Cell bodies were only found in the hypothalamus: a high density in the paraventricular and supraoptic hypothalamic nuclei and a low density in the anterior, lateral and dorsal hypothalamic areas, around the fornix, and in the posterior and ventromedial hypothalamic nuclei. The widespread distribution of calcitonin gene-related peptide in the alpaca diencephalon suggests that it is involved in many physiological actions that must be investigated in-depth in the future, since alpacas lives from 0 m above sea level to altitudes of up to 5000 m altitude and hence the involvement of neuropeptides in special and unique regulatory physiological mechanisms could be suggested., (Copyright © 2012 Elsevier B.V. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
46. [Analysis of cost-effectiveness in the diagnosis of fever of unknown origin and the role of (18)F-FDG PET-CT: a proposal of diagnostic algorithm].
- Author
-
Becerra Nakayo EM, García Vicente AM, Soriano Castrejón AM, Mendoza Narváez JA, Talavera Rubio MP, Poblete García VM, and Cordero García JM
- Subjects
- Aged, Aged, 80 and over, Algorithms, Blood Chemical Analysis economics, Blood Chemical Analysis statistics & numerical data, Cost-Benefit Analysis, Diagnosis, Differential, Diagnostic Tests, Routine economics, Diagnostic Tests, Routine statistics & numerical data, Early Diagnosis, False Negative Reactions, False Positive Reactions, Female, Fever of Unknown Origin diagnostic imaging, Fever of Unknown Origin economics, Fever of Unknown Origin etiology, Hospitalization economics, Humans, Length of Stay economics, Length of Stay statistics & numerical data, Male, Middle Aged, Retrospective Studies, Serologic Tests economics, Serologic Tests statistics & numerical data, Spain, Unnecessary Procedures economics, Young Adult, Fever of Unknown Origin diagnosis, Fluorine Radioisotopes economics, Fluorodeoxyglucose F18 economics, Hospital Costs statistics & numerical data, Multimodal Imaging economics, Positron-Emission Tomography, Radiopharmaceuticals economics, Tomography, X-Ray Computed
- Abstract
Aim: To analyze the costs of Fever of Unknown Origin (FUO) prior to the PET-CT study. To determine the effectiveness of PET-CT in the diagnosis of FUO. A proposal of diagnostic algorithm., Material and Methods: A retrospective study was performed that included 20 patients who had been studied between January 2007 and January 2011, with a mean age of 57.75 years and FUO diagnosis. All underwent a PET-CT study with (18)F-FDG. Individual and mean costs of FUO in these patients were assessed, including hospitalization days and complementary tests prior to the PET-CT study. The effectiveness of the PET-CT study in the diagnosis of FUO was analyzed. Costs of the FUO process were determined, including those of the PET-CT study, and if it had been done earlier in the diagnostic process., Results: Mean hospital stay per patient until the PET-CT study was 28 days. The cost per hospitalization day was 342 €. Average cost per patient in complementary tests was 1395 €. Total cost of the FUO process until the PET-CT study was around 11167 € per patient. The PET-CT study showed a 78% sensitivity, 83% specificity, 92% PPV and 62% NPV. If PET-CT had been performed earlier in the FUO process, assuming the same effectiveness, 5471 € per patient would have been saved., Conclusion: The PET-CT study could be cost-effective in the FUO process if used at an early stage, helping to establish an early diagnosis, reducing hospitalization days due to diagnostic purposes and the repetition of unnecessary tests., (Copyright © 2011 Elsevier España, S.L. y SEMNIM. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
47. [Parascapular lipoma with expression of somatostatin receptors detected by (99m)Tc-EDDA/HYNIC-TOC scintigraphy].
- Author
-
Mendoza Narváez JA, Bellón Guardia ME, García Vicente AM, Palomar Muñoz A, Talavera Rubio MP, and Soriano Castrejón AM
- Subjects
- Biopsy, Fine-Needle, Diagnosis, Differential, Female, Humans, Lipoma chemistry, Lipoma pathology, Middle Aged, Neoplasm Recurrence, Local diagnosis, Neoplasm Recurrence, Local diagnostic imaging, Neuroendocrine Tumors diagnostic imaging, Neuroendocrine Tumors secondary, Neuroendocrine Tumors surgery, Pancreatectomy, Pancreatic Neoplasms surgery, Radionuclide Imaging, Reoperation, Shoulder, Soft Tissue Neoplasms chemistry, Soft Tissue Neoplasms pathology, Stomach Neoplasms secondary, Stomach Neoplasms surgery, Biomarkers, Tumor analysis, Lipoma diagnostic imaging, Neoplasms, Second Primary diagnostic imaging, Octreotide, Organotechnetium Compounds, Radiopharmaceuticals, Receptors, Somatostatin analysis, Soft Tissue Neoplasms diagnostic imaging
- Published
- 2012
- Full Text
- View/download PDF
48. Extrasynaptic neurotransmission in the modulation of brain function. Focus on the striatal neuronal-glial networks.
- Author
-
Fuxe K, Borroto-Escuela DO, Romero-Fernandez W, Diaz-Cabiale Z, Rivera A, Ferraro L, Tanganelli S, Tarakanov AO, Garriga P, Narváez JA, Ciruela F, Guescini M, and Agnati LF
- Abstract
Extrasynaptic neurotransmission is an important short distance form of volume transmission (VT) and describes the extracellular diffusion of transmitters and modulators after synaptic spillover or extrasynaptic release in the local circuit regions binding to and activating mainly extrasynaptic neuronal and glial receptors in the neuroglial networks of the brain. Receptor-receptor interactions in G protein-coupled receptor (GPCR) heteromers play a major role, on dendritic spines and nerve terminals including glutamate synapses, in the integrative processes of the extrasynaptic signaling. Heteromeric complexes between GPCR and ion-channel receptors play a special role in the integration of the synaptic and extrasynaptic signals. Changes in extracellular concentrations of the classical synaptic neurotransmitters glutamate and GABA found with microdialysis is likely an expression of the activity of the neuron-astrocyte unit of the brain and can be used as an index of VT-mediated actions of these two neurotransmitters in the brain. Thus, the activity of neurons may be functionally linked to the activity of astrocytes, which may release glutamate and GABA to the extracellular space where extrasynaptic glutamate and GABA receptors do exist. Wiring transmission (WT) and VT are fundamental properties of all neurons of the CNS but the balance between WT and VT varies from one nerve cell population to the other. The focus is on the striatal cellular networks, and the WT and VT and their integration via receptor heteromers are described in the GABA projection neurons, the glutamate, dopamine, 5-hydroxytryptamine (5-HT) and histamine striatal afferents, the cholinergic interneurons, and different types of GABA interneurons. In addition, the role in these networks of VT signaling of the energy-dependent modulator adenosine and of endocannabinoids mainly formed in the striatal projection neurons will be underlined to understand the communication in the striatal cellular networks.
- Published
- 2012
- Full Text
- View/download PDF
49. Changing trends in the epidemiology of pyogenic vertebral osteomyelitis: the impact of cases with no microbiologic diagnosis.
- Author
-
Lora-Tamayo J, Euba G, Narváez JA, Murillo O, Verdaguer R, Sobrino B, Narváez J, Nolla JM, and Ariza J
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Incidence, Male, Middle Aged, Osteomyelitis diagnosis, Retrospective Studies, Spinal Diseases diagnosis, Osteomyelitis epidemiology, Osteomyelitis microbiology, Spinal Diseases epidemiology, Spinal Diseases microbiology, Spine microbiology
- Abstract
Objectives: The observed higher incidence of pyogenic vertebral osteomyelitis (PVO) may entail an increasing number of patients with no microbiologic diagnosis. The true incidence of these cases, how exhaustive the etiologic diagnostic efforts must be, and the usefulness of an empirical antibiotic therapy are not well defined., Methods: Retrospective analysis of all cases of vertebral osteomyelitis in our center (1991-2009) and retrospective analysis of cases of PVO (2005-2009). Clinical data, diagnostic procedures, treatment, and outcome were reviewed. A comparative analysis between microbiologically confirmed PVO (MCPVO) and probable PVO (PPVO) was performed., Results: Increasing incidence of PVO (+0.047 episodes/100,000 inhabitants-year). During the last decade, there was an increase of PPVO (+0.059 episodes/100,000 inhabitants-year) with stable incidence of MCPVO. During 2005-2009, there were 72 patients [47 (65%) MCPVO and 25 (35%) PPVO]. 60% men; mean age was 66 years. Bacteremia was found in 59%. Computed tomographic guided vertebral biopsy, positive in 7/36 (19%), was more successful among patients with bacteremia. Among MCPVO, there was an increasing proportion of less virulent bacteria. Cases of MCPVO presented more frequently with sepsis, fever, and high acute-phase reactants, and PPVO cases were mostly treated with oral fluoroquinolones plus rifampin. No differences were found between both groups in outcome (93% success, 22% sequelae)., Conclusions: An epidemiologic change of PVO is suggested by a higher incidence of PPVO and the isolation of less virulent microorganisms among MCPVO. In this setting, the availability of an oral and effective empirical antibiotic therapy may challenge an exhaustive prosecution of the etiology., (Copyright © 2011 Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
50. Mapping of somatostatin-28 (1-12) in the alpaca diencephalon.
- Author
-
Coveñas R, Mangas A, Medina LE, Sánchez ML, Aguilar LA, Díaz-Cabiale Z, and Narváez JA
- Subjects
- Animals, Immunohistochemistry, Male, Peptide Fragments analysis, Somatostatin-28 analysis, Camelids, New World metabolism, Diencephalon metabolism, Peptide Fragments metabolism, Somatostatin-28 metabolism
- Abstract
Using an immunocytochemical technique, we report for the first time the distribution of immunoreactive cell bodies and fibers containing somatostatin-28 (1-12) in the alpaca diencephalon. Somatostatin-28 (1-12)-immunoreactive cell bodies were only observed in the hypothalamus (lateral hypothalamic area, arcuate nucleus and ventromedial hypothalamic nucleus). However, immunoreactive fibers were widely distributed throughout the thalamus and hypothalamus. A high density of such fibers was observed in the central medial thalamic nucleus, laterodorsal thalamic nucleus, lateral habenular nucleus, mediodorsal thalamic nucleus, paraventricular thalamic nucleus, reuniens thalamic nucleus, rhomboid thalamic nucleus, subparafascicular thalamic nucleus, anterior hypothalamic area, arcuate nucleus, dorsal hypothalamic area, around the fornix, lateral hypothalamic area, lateral mammilary nucleus, posterior hypothalamic nucleus, paraventricular hypothalamic nucleus, suprachiasmatic nucleus, supraoptic hypothalamic nucleus, and in the ventromedial hypothalamic nucleus. The widespread distribution of somatostatin-28 (1-12) in the thalamus and hypothalamus of the alpaca suggests that the neuropeptide could be involved in many physiological actions., (Copyright © 2011 Elsevier B.V. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.